Generic Treprostinil Available as Under-the-skin Injection

Generic Treprostinil Available as Under-the-skin Injection

295104

Generic Treprostinil Available as Under-the-skin Injection

Sandoz‘s generic treprostinil injection now is available for subcutaneous (under-the-skin) administration to treat  pulmonary arterial hypertension (PAH), the company announced in a press release. Treprostinil first was approved to treat PAH in the U.S. in 2002. It was developed by United Therapeutics, which markets the medication under the brand name Remodulin. Generic formulations of the medication — meaning versions that contain the same active ingredient(s), with the same strengths as the brand-name medicine, but are…

You must be logged in to read/download the full post.